A Novel and Lethal De Novo LQT-3 Mutation in a Newborn with Distinct Molecular Pharmacology and Therapeutic Response

• John R. Bankston ,

  Contributed equally to this work with: John R. Bankston, Minerva Yue

  Affiliation Department of Pharmacology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Minerva Yue ,

  Contributed equally to this work with: John R. Bankston, Minerva Yue

  Affiliation Department of Pharmacology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Wendy Chung,

  Affiliation Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Meghan Spyres,

  Affiliation College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Robert H. Pass,

  Affiliation Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Eric Silver,

  Affiliation Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Kevin J. Sampson,

  Affiliation Department of Pharmacology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯
• Robert S. Kass

  *To whom correspondence should be addressed. E-mail: rsk20@columbia.edu

  Affiliation Department of Pharmacology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, United States of America

  ⨯